Sermorelin is strictly for laboratory research and is commonly employed in the following investigational areas:

Somatotropic Axis & Pituitary Function

Sermorelin is extensively utilized as a chemical probe to study the hypothalamic-pituitary-somatotropic axis. Researchers use it to quantify the stimulation of endogenous GH and subsequent Insulin-like Growth Factor 1 (IGF-1) production without suppressing natural pituitary function.

Body Composition and Metabolic Homeostasis

In experimental models of age-related GH decline, Sermorelin is investigated for its downstream effects on metabolic parametersgrowth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women – PubMed]. Assays focus on how restoring pulsatile GH secretion impacts lean muscle mass preservation, lipid metabolism, and insulin sensitivitygrowth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women – PubMed].

Sleep Architecture and Neurobiology

Because endogenous GH secretion is intimately linked with slow-wave sleep, Sermorelin is employed in neurobiological research to study the bidirectional relationship between GHRH receptor activation and sleep architecture. It is also used to investigate cognitive markers and the preservation of the neuroendocrine axis during aging.

Pathway / Mechanistic Context

• GHRHR Activation: Sermorelin binds to GHRH receptors on somatotrophs in the anterior pituitary.
• Signal Transduction: Activation leads to an increase in intracellular cAMP via adenylate cyclase.
• Pulsatile Secretion: This signaling cascade triggers the synthesis and episodic (pulsatile) release of growth hormone.
• Feedback Regulation: The resulting GH release is regulated by somatostatin (inhibitory), ensuring physiological hormone rhythms and preventing receptor downregulation.

Preclinical Research Summary

Published preclinical literature documents investigations of Sermorelin across multiple experimental models:

• Endocrine Models: Studies in aged mammalian models show that Sermorelin administration can elevate mean 24-h GH, peak GH amplitude, and restore IGF-1 levels.
• Cellular Aging: Research involving SAMP8 mice has investigated GHRH modulation for its effects on telomerase activity and oxidative stress markers in the brain.
• Tissue Composition: Data from metabolic assays indicate that restoring the GH-IGF-1 axis via GHRH analogues can positively influence nitrogen balance and lean mass in specific in vivo modelsgrowth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women – PubMed].

Form & Analytical Testing

This material is produced via robust chemical synthesis and supplied as a lyophilized (freeze-dried) powder.

• Lyophilization: Removes water content under vacuum to maintain compound integrity and extend shelf-life.
• Identity Verification: Each lot undergoes Mass Spectrometry (MS) to confirm molecular weight and identity.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) is performed to ensure the product meets the ≥99% purity standard required for reproducible research data.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

• Prakash, A., & Goa, K. L. (1999). Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs, 12(2), 139-157. https://doi.org/10.2165/00063030-199912020-00007
• Walker, R. F. (2006). Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?. Clinical interventions in aging, 1(4), 307.https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
• Sigalos, J. T., & Pastuszak, A. W. (2018). The safety and efficacy of growth hormone secretagogues. Sexual medicine reviews, 6(1), 45-53. https://doi.org/10.1016/j.sxmr.2017.02.004
• Vittone, J., et al. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. The Journal of Clinical Endocrinology & Metabolism, 82(5), 3943-3948. https://doi.org/10.1210/jcem.82.5.3943
• Vitiello, M. V., et al. (2006). Treating age-related changes in somatotrophic hormones, sleep, and cognition. Dialogues in clinical neuroscience, 8(4), 433–438. https://pmc.ncbi.nlm.nih.gov/articles/PMC3181657/

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.